Prisma ORM VS Modius

• Type-Safe API
  Prisma provides a type-safe API, reducing the likelihood of type-related errors during development and improving the developer experience.
• Auto-Generated CRUD Operations
  Prisma automatically generates CRUD operations for your database models, which can save a significant amount of development time.
• Flexible Data Modeling
  Prisma supports a flexible data modeling approach with its Prisma Schema Language (PSL), making it easier to design and iterate on your database schema.
• Database Agnostic
  Prisma works with various databases (PostgreSQL, MySQL, SQLite, MongoDB), providing a consistent API regardless of the underlying database technology.
• Strong Community and Documentation
  Prisma has an active community and extensive documentation, which can help developers resolve issues and learn best practices.

• Non-invasive neurostimulation
  Modius offers a non-invasive approach to health and wellness through neurostimulation technology, which targets the vestibular nerve to potentially influence metabolism, appetite, and body composition without surgery or medication.
• Easy to use
  The Modius headset is designed for home use with simple operation. Users typically wear the device for a short session each day, making it convenient to integrate into daily routines without requiring clinical visits.
• Drug-free approach
  For individuals seeking alternatives to pharmaceutical weight management or wellness solutions, Modius provides a drug-free option that works through electrical stimulation of neural pathways.
• Companion app
  Modius comes with a companion smartphone app that helps users track their sessions, monitor progress, and adjust settings, providing a guided and connected user experience.
• Backed by neuroscience research
  The technology is rooted in neuroscience principles related to vestibular nerve stimulation and its connection to the hypothalamus, which plays a role in regulating appetite, metabolism, and fat storage.

Possible disadvantages

• Mixed user results
  Results vary significantly among users, with some reporting noticeable benefits while others experience little to no change. The inconsistency in outcomes makes it difficult to guarantee effectiveness for every individual.
• Limited clinical evidence
  While the underlying neuroscience concepts are established, the specific claims made by Modius regarding weight loss and body composition changes have limited large-scale, peer-reviewed clinical trial data to fully support them.
• Relatively expensive
  The Modius device comes at a premium price point, which may be a barrier for many consumers, especially given the uncertainty around individual results and the availability of other wellness options.
• Potential side effects
  Some users report mild side effects such as dizziness, nausea, or discomfort during or after sessions due to the vestibular nerve stimulation, which can be unpleasant and may discourage continued use.
• Requires consistent long-term use
  To see any potential results, users typically need to commit to regular daily sessions over weeks or months. This long-term commitment may be difficult to maintain, and discontinuing use may reverse any benefits gained.

• Building Real-time Magic: Supabase Subscriptions in Next.js 15 ⚡

  Head to your Supabase dashboard and run this SQL or you use can Prisma ORM, which makes schema management easier to maintain and version control as your project grows:. - Source: dev.to / about 1 year ago

• When Embedded AuthN Meets Embedded AuthZ - Building Multi-Tenant Apps With Better-Auth and ZenStack

  While better-auth solves the problem of determining a user's identity and roles, ZenStack continues from there and uses such information to control what actions the user can perform on a piece of data. ZenStack is built above Prisma ORM... - Source: dev.to / almost 2 years ago

• Building Multi-Tenant Apps Using StackAuth's "Teams" and Next.js

  Prisma: the ORM that we use to talk to the database. - Source: dev.to / almost 2 years ago

View more

Tracking Modius since Nov 2022.